Wan_2021_ACS.Omega_6_23347

Reference

Title : Pd-Catalyzed Direct Modification of an Anti-Alzheimer's Disease Drug: Synthesis and Biological Evaluation of alpha-Aryl Donepezil Analogues - Wan_2021_ACS.Omega_6_23347
Author(s) : Wan LX , Miao SX , He ZX , Li X , Zhou XL , Gao F
Ref : ACS Omega , 6 :23347 , 2021
Abstract :

Palladium/BuAd(2)P efficiently catalyzed the direct alpha-arylation of ketone in the anti-Alzheimer's disease drug donepezil, leading to 15 aryldonepezil analogues exhibiting high selective inhibition of acetylcholinesterase (AChE). The cell-based assays revealed that the 3-methylpridinyl analogue (12) shows significantly lower toxicity compared to donepezil and remarkable neuroprotective activity against H(2)O(2)-induced damage in SH-SY5Y cells. Docking results of compound 12 also interpreted the possible mechanism of the selective inhibition between AChE and butyrylcholinesterase (BuChE).

PubMedSearch : Wan_2021_ACS.Omega_6_23347
PubMedID: 34549134

Related information

Citations formats

Wan LX, Miao SX, He ZX, Li X, Zhou XL, Gao F (2021)
Pd-Catalyzed Direct Modification of an Anti-Alzheimer's Disease Drug: Synthesis and Biological Evaluation of alpha-Aryl Donepezil Analogues
ACS Omega 6 :23347

Wan LX, Miao SX, He ZX, Li X, Zhou XL, Gao F (2021)
ACS Omega 6 :23347